0000950170-24-066175.txt : 20240529 0000950170-24-066175.hdr.sgml : 20240529 20240529201132 ACCESSION NUMBER: 0000950170-24-066175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coleman Mark CENTRAL INDEX KEY: 0001658379 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37635 FILM NUMBER: 241000409 MAIL ADDRESS: STREET 1: 25 BROADWAY STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: (212) 332-3241 MAIL ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 4 1 ownership.xml 4 X0508 4 2024-05-28 0001579428 Axsome Therapeutics, Inc. AXSM 0001658379 Coleman Mark C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 true false false false true Common Stock 2024-05-28 4 S false 5249 75.2095 D 19848 D Common Stock 2024-05-29 4 S false 5248 75.1396 D 14600 D Such transaction was pursuant to a pre-approved 10b5-1 plan. Represents the sale of underlying shares of previously exercised stock options. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.88. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.90. /s/ Herriot Tabuteau, M.D., Attorney-in-Fact 2024-05-29